| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 65,658 | 52,234 | 44,774 | 60,569 | | Cost of Revenue | 13,207 | 11,411 | 9,905 | 12,972 | | | Gross Profit | 52,451 | 40,823 | 34,869 | 47,597 | | | Operating Expenses | | Research Development | 26,643 | 22,837 | 20,074 | 20,932 | | Selling General and Administrative | 29,122 | 29,495 | 25,015 | 34,638 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,562 | 2,501 | 2,502 | 3,078 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,876) | (14,010) | (12,722) | (11,051) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (1,098) | | Earnings Before Interest And Taxes | (9,938) | (14,010) | (12,722) | (12,149) | | Interest Expense | (2,645) | 1,354 | 1,291 | (505) | | Income Before Tax | (7,293) | (15,364) | (14,013) | (11,644) | | Income Tax Expense | 22 | (47) | (47) | (1,108) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,315) | (15,317) | (13,966) | (10,536) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,315) | (15,317) | (13,966) | (10,536) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,315) | ($15,317) | ($13,966) | ($10,536) |
|
0.20% Nasdaq 
Income Statement
